Dr. Jürgen Beck

Chief Development Officer of PAION AG, Managing Director of PAION Deutschland GmbH

 

Dr. Jürgen Beck was appointed Chief Development Officer of PAION AG in December 2017 and within the Management Board, he is responsible for product development, in particular for the remimazolam development program in procedural sedation in the U.S. and for the EU Phase III program in general anesthesia.

Dr. Beck has over 25 years of experience in the European pharma business, with positions held in various drug development projects. As a graduated physician and having a diploma in business administration, he held inter alia various senior management positions at Synthélabo for many years, was longtime Managing Director of the contract research organization Monitoring Force GmbH, Senior Vice President of Medical Affairs at Epigenomics and Vice President of Clinical Operations Europe at InterMune International AG.